ID   FAD1_HUMAN              Reviewed;         587 AA.
AC   Q8NFF5; Q8N5J1; Q8N686; Q8WU93; Q8WUJ4; Q96CR8; Q99764; Q9HBN6;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   15-MAR-2017, entry version 130.
DE   RecName: Full=FAD synthase;
DE            EC=2.7.7.2 {ECO:0000269|PubMed:16643857};
DE   AltName: Full=FAD pyrophosphorylase;
DE   AltName: Full=FMN adenylyltransferase;
DE   AltName: Full=Flavin adenine dinucleotide synthase;
DE   Includes:
DE     RecName: Full=Molybdenum cofactor biosynthesis protein-like region;
DE   Includes:
DE     RecName: Full=FAD synthase region;
DE   Flags: Precursor;
GN   Name=FLAD1; ORFNames=PP591;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ALTERNATIVE SPLICING (ISOFORM
RP   2), CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, AND
RP   FUNCTION.
RC   TISSUE=Skin;
RX   PubMed=16643857; DOI=10.1016/j.bbrc.2006.04.003;
RA   Brizio C., Galluccio M., Wait R., Torchetti E.M., Bafunno V.,
RA   Accardi R., Gianazza E., Indiveri C., Barile M.;
RT   "Over-expression in Escherichia coli and characterization of two
RT   recombinant isoforms of human FAD synthetase.";
RL   Biochem. Biophys. Res. Commun. 344:1008-1016(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Liver;
RA   Fischer M.J., Kempter K., Bacher A.;
RT   "Cloning, expression and characterization of a human FAD synthetase.";
RL   Submitted (FEB-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RA   Chen X.G., Li Y.;
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H.,
RA   Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y.,
RA   Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S.,
RA   Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (DEC-2006) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 10-587 (ISOFORM 5), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 256-587 (ISOFORM 1).
RC   TISSUE=Brain, Colon, Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 151-587 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9110174;
RA   Yu W., Andersson B., Worley K.C., Muzny D.M., Ding Y., Liu W.,
RA   Ricafrente J.Y., Wentland M.A., Lennon G., Gibbs R.A.;
RT   "Large-scale concatenation cDNA sequencing.";
RL   Genome Res. 7:353-358(1997).
RN   [9]
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND COFACTOR.
RX   PubMed=17049878; DOI=10.1016/j.pep.2006.09.002;
RA   Galluccio M., Brizio C., Torchetti E.M., Ferranti P., Gianazza E.,
RA   Indiveri C., Barile M.;
RT   "Over-expression in Escherichia coli, purification and
RT   characterization of isoform 2 of human FAD synthetase.";
RL   Protein Expr. Purif. 52:175-181(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106 AND SER-563, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-563, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [13]
RP   SUBCELLULAR LOCATION.
RX   PubMed=20060505; DOI=10.1016/j.mito.2009.12.149;
RA   Torchetti E.M., Brizio C., Colella M., Galluccio M., Giancaspero T.A.,
RA   Indiveri C., Roberti M., Barile M.;
RT   "Mitochondrial localization of human FAD synthetase isoform 1.";
RL   Mitochondrion 10:263-273(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-563, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   INVOLVEMENT IN LSMFLAD, VARIANT LSMFLAD CYS-530 (ISOFORM 2),
RP   CHARACTERIZATION OF VARIANT LSMFLAD CYS-530 (ISOFORM 2), VARIANT
RP   LEU-107, AND FUNCTION.
RX   PubMed=27259049; DOI=10.1016/j.ajhg.2016.04.006;
RA   Olsen R.K., Konarikova E., Giancaspero T.A., Mosegaard S.,
RA   Boczonadi V., Matakovic L., Veauville-Merllie A., Terrile C.,
RA   Schwarzmayr T., Haack T.B., Auranen M., Leone P., Galluccio M.,
RA   Imbard A., Gutierrez-Rios P., Palmfeldt J., Graf E., Vianey-Saban C.,
RA   Oppenheim M., Schiff M., Pichard S., Rigal O., Pyle A., Chinnery P.F.,
RA   Konstantopoulou V., Moeslinger D., Feichtinger R.G., Talim B.,
RA   Topaloglu H., Coskun T., Gucer S., Botta A., Pegoraro E., Malena A.,
RA   Vergani L., Mazza D., Zollino M., Ghezzi D., Acquaviva C., Tyni T.,
RA   Boneh A., Meitinger T., Strom T.M., Gregersen N., Mayr J.A.,
RA   Horvath R., Barile M., Prokisch H.;
RT   "Riboflavin-responsive and -non-responsive mutations in FAD synthase
RT   cause multiple Acyl-CoA dehydrogenase and combined respiratory-chain
RT   deficiency.";
RL   Am. J. Hum. Genet. 98:1130-1145(2016).
CC   -!- FUNCTION: Catalyzes the adenylation of flavin mononucleotide (FMN)
CC       to form flavin adenine dinucleotide (FAD) coenzyme.
CC       {ECO:0000269|PubMed:16643857, ECO:0000269|PubMed:27259049}.
CC   -!- CATALYTIC ACTIVITY: ATP + FMN = diphosphate + FAD.
CC       {ECO:0000269|PubMed:16643857}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:16643857,
CC         ECO:0000269|PubMed:17049878};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.5 uM for FMN {ECO:0000269|PubMed:16643857,
CC         ECO:0000269|PubMed:17049878};
CC         KM=0.36 uM for FMN (isoform 2) {ECO:0000269|PubMed:16643857,
CC         ECO:0000269|PubMed:17049878};
CC         Vmax=6.1 nmol/min/mg enzyme {ECO:0000269|PubMed:16643857,
CC         ECO:0000269|PubMed:17049878};
CC         Vmax=3.9 nmol/min/mg enzyme (isoform 2)
CC         {ECO:0000269|PubMed:16643857, ECO:0000269|PubMed:17049878};
CC   -!- PATHWAY: Cofactor biosynthesis; FAD biosynthesis; FAD from FMN:
CC       step 1/1.
CC   -!- INTERACTION:
CC       Q04864:REL; NbExp=3; IntAct=EBI-742815, EBI-307352;
CC       O00560:SDCBP; NbExp=3; IntAct=EBI-742815, EBI-727004;
CC       P15884:TCF4; NbExp=3; IntAct=EBI-742815, EBI-533224;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Mitochondrion matrix
CC       {ECO:0000269|PubMed:20060505}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=FADS1 {ECO:0000303|PubMed:27259049};
CC         IsoId=Q8NFF5-1; Sequence=Displayed;
CC       Name=2; Synonyms=FADS2 {ECO:0000303|PubMed:27259049};
CC         IsoId=Q8NFF5-2; Sequence=VSP_027947;
CC       Name=3;
CC         IsoId=Q8NFF5-3; Sequence=VSP_027947, VSP_027954;
CC       Name=4;
CC         IsoId=Q8NFF5-4; Sequence=VSP_027948, VSP_027949, VSP_027951,
CC                                  VSP_027952;
CC       Name=5;
CC         IsoId=Q8NFF5-5; Sequence=VSP_027948, VSP_027949, VSP_027950,
CC                                  VSP_027953;
CC   -!- DOMAIN: The molybdenum cofactor biosynthesis protein-like region
CC       may not be functional.
CC   -!- DISEASE: Lipid storage myopathy due to flavin adenine dinucleotide
CC       synthetase deficiency (LSMFLAD) [MIM:255100]: An autosomal
CC       recessive, inborn error of metabolism characterized by variable
CC       mitochondrial dysfunction. Clinical features range from severe
CC       cardiac and respiratory insufficiency with onset in infancy and
CC       resulting in early death, to mild muscle weakness with onset in
CC       adulthood. Some patients show significant improvement with
CC       riboflavin treatment. Analysis of skeletal muscle show multiple
CC       mitochondrial respiratory chain deficiency and a lipid storage
CC       myopathy in most patients. {ECO:0000269|PubMed:27259049}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the MoaB/Mog
CC       family. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the PAPS
CC       reductase family. FAD1 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ458779; ABE65383.1; -; mRNA.
DR   EMBL; AF481877; AAO49318.1; -; mRNA.
DR   EMBL; AF520568; AAM77338.1; -; mRNA.
DR   EMBL; AF218022; AAG17264.1; -; mRNA.
DR   EMBL; AL451085; CAI13259.1; -; Genomic_DNA.
DR   EMBL; AL451085; CAI13260.1; -; Genomic_DNA.
DR   EMBL; AL451085; CAI13261.1; -; Genomic_DNA.
DR   EMBL; AL451085; CAI13262.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53154.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53155.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53158.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53159.1; -; Genomic_DNA.
DR   EMBL; BC011378; AAH11378.1; -; mRNA.
DR   EMBL; BC014012; AAH14012.2; -; mRNA.
DR   EMBL; BC020253; AAH20253.1; -; mRNA.
DR   EMBL; BC021096; AAH21096.2; -; mRNA.
DR   EMBL; BC032323; AAH32323.1; -; mRNA.
DR   EMBL; U79241; AAB50199.1; -; mRNA.
DR   CCDS; CCDS1078.1; -. [Q8NFF5-1]
DR   CCDS; CCDS1079.1; -. [Q8NFF5-2]
DR   CCDS; CCDS53371.1; -. [Q8NFF5-3]
DR   CCDS; CCDS53372.1; -. [Q8NFF5-4]
DR   RefSeq; NP_001171820.1; NM_001184891.1. [Q8NFF5-3]
DR   RefSeq; NP_001171821.1; NM_001184892.1. [Q8NFF5-4]
DR   RefSeq; NP_079483.3; NM_025207.4. [Q8NFF5-1]
DR   RefSeq; NP_958800.1; NM_201398.2. [Q8NFF5-2]
DR   UniGene; Hs.118666; -.
DR   ProteinModelPortal; Q8NFF5; -.
DR   SMR; Q8NFF5; -.
DR   BioGrid; 123221; 29.
DR   IntAct; Q8NFF5; 25.
DR   MINT; MINT-3042841; -.
DR   STRING; 9606.ENSP00000292180; -.
DR   iPTMnet; Q8NFF5; -.
DR   PhosphoSitePlus; Q8NFF5; -.
DR   BioMuta; FLAD1; -.
DR   DMDM; 74751275; -.
DR   EPD; Q8NFF5; -.
DR   MaxQB; Q8NFF5; -.
DR   PaxDb; Q8NFF5; -.
DR   PeptideAtlas; Q8NFF5; -.
DR   PRIDE; Q8NFF5; -.
DR   DNASU; 80308; -.
DR   Ensembl; ENST00000292180; ENSP00000292180; ENSG00000160688. [Q8NFF5-1]
DR   Ensembl; ENST00000315144; ENSP00000317296; ENSG00000160688. [Q8NFF5-2]
DR   Ensembl; ENST00000368431; ENSP00000357416; ENSG00000160688. [Q8NFF5-4]
DR   Ensembl; ENST00000368432; ENSP00000357417; ENSG00000160688. [Q8NFF5-3]
DR   GeneID; 80308; -.
DR   KEGG; hsa:80308; -.
DR   UCSC; uc001fgc.4; human. [Q8NFF5-1]
DR   CTD; 80308; -.
DR   DisGeNET; 80308; -.
DR   GeneCards; FLAD1; -.
DR   HGNC; HGNC:24671; FLAD1.
DR   HPA; HPA028476; -.
DR   HPA; HPA028486; -.
DR   HPA; HPA028563; -.
DR   MIM; 255100; phenotype.
DR   MIM; 610595; gene.
DR   neXtProt; NX_Q8NFF5; -.
DR   OpenTargets; ENSG00000160688; -.
DR   PharmGKB; PA142671759; -.
DR   eggNOG; ENOG410IMG8; Eukaryota.
DR   eggNOG; KOG2644; Eukaryota.
DR   eggNOG; COG0175; LUCA.
DR   eggNOG; COG1058; LUCA.
DR   GeneTree; ENSGT00390000007266; -.
DR   HOVERGEN; HBG058211; -.
DR   InParanoid; Q8NFF5; -.
DR   KO; K00953; -.
DR   OMA; CVLENVY; -.
DR   OrthoDB; EOG091G0PRM; -.
DR   PhylomeDB; Q8NFF5; -.
DR   TreeFam; TF314056; -.
DR   BioCyc; MetaCyc:HS08520-MONOMER; -.
DR   BRENDA; 2.7.7.2; 2681.
DR   Reactome; R-HSA-196843; Vitamin B2 (riboflavin) metabolism.
DR   SABIO-RK; Q8NFF5; -.
DR   UniPathway; UPA00277; UER00407.
DR   ChiTaRS; FLAD1; human.
DR   GenomeRNAi; 80308; -.
DR   PRO; PR:Q8NFF5; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000160688; -.
DR   CleanEx; HS_FLAD1; -.
DR   ExpressionAtlas; Q8NFF5; baseline and differential.
DR   Genevisible; Q8NFF5; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003919; F:FMN adenylyltransferase activity; IBA:GO_Central.
DR   GO; GO:0006747; P:FAD biosynthetic process; IBA:GO_Central.
DR   GO; GO:0055114; P:oxidation-reduction process; IBA:GO_Central.
DR   GO; GO:0006771; P:riboflavin metabolic process; TAS:Reactome.
DR   CDD; cd00885; cinA; 1.
DR   CDD; cd01713; PAPS_reductase; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   Gene3D; 3.40.980.10; -; 1.
DR   InterPro; IPR012183; FAD_synth_MoaB/Mog-bd.
DR   InterPro; IPR001453; MoaB/Mog_dom.
DR   InterPro; IPR002500; PAPS_reduct.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF00994; MoCF_biosynth; 1.
DR   Pfam; PF01507; PAPS_reduct; 2.
DR   PIRSF; PIRSF036620; MPTbdFAD; 1.
DR   SMART; SM00852; MoCF_biosynth; 1.
DR   SUPFAM; SSF53218; SSF53218; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Disease mutation; FAD; Flavoprotein; FMN; Mitochondrion;
KW   Nucleotide-binding; Nucleotidyltransferase; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transferase; Transit peptide.
FT   TRANSIT       1     17       Mitochondrion. {ECO:0000255}.
FT   CHAIN        18    587       FAD synthase.
FT                                /FTId=PRO_0000302737.
FT   REGION      114    205       Molybdenum cofactor biosynthesis protein-
FT                                like.
FT   REGION      398    555       FAD synthase.
FT   MOD_RES     106    106       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976}.
FT   MOD_RES     378    378       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8R123}.
FT   MOD_RES     378    378       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8R123}.
FT   MOD_RES     563    563       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     97       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_027947.
FT   VAR_SEQ       1     30       Missing (in isoform 4 and isoform 5).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:15498874}.
FT                                /FTId=VSP_027948.
FT   VAR_SEQ      31    124       LEGSTRTPALPHCLFWLLQVPSTQDPLFPGYGPQCPVDLAG
FT                                PPCLRPLFGGLGGYWRALQRGREGRTMTSRASELSPGRSVT
FT                                AGIIIVGDEILK -> MQPSSSTPPLHPYSTDGLIFPFNPQ
FT                                (in isoform 4 and isoform 5).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:15498874}.
FT                                /FTId=VSP_027949.
FT   VAR_SEQ     374    437       SSLGKKVAGALQTIETSLAQYSLTQLCVGFNGGKDCTALLH
FT                                LFHAAVQRKLPDVPNPLQILYIR -> NYLMFQTPSRSCIS
FT                                AASPLSLSWNSFYRTLSREQAIPENQIASPPSEAKGAEEPW
FT                                MGPFPGQQG (in isoform 5).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_027950.
FT   VAR_SEQ     374    393       SSLGKKVAGALQTIETSLAQ -> RDLMEEGHYAQSHWWHP
FT                                RSQ (in isoform 4).
FT                                {ECO:0000303|PubMed:15498874}.
FT                                /FTId=VSP_027951.
FT   VAR_SEQ     394    587       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15498874}.
FT                                /FTId=VSP_027952.
FT   VAR_SEQ     438    587       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_027953.
FT   VAR_SEQ     544    587       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_027954.
FT   VARIANT     107    107       P -> L (in dbSNP:rs773925274).
FT                                {ECO:0000269|PubMed:27259049}.
FT                                /FTId=VAR_077069.
FT   VARIANT     530    530       R -> C (in LSMFLAD; decreased protein
FT                                stability; decreased affinity for FMN;
FT                                reduced Vmax; decreased FMN
FT                                adenylyltransferase activity;
FT                                dbSNP:rs771466122).
FT                                {ECO:0000269|PubMed:27259049}.
FT                                /FTId=VAR_077070.
SQ   SEQUENCE   587 AA;  65266 MW;  F95918B15D9D8106 CRC64;
     MGWDLGTRLF QRQEQRSRLS RIWLEKTRVF LEGSTRTPAL PHCLFWLLQV PSTQDPLFPG
     YGPQCPVDLA GPPCLRPLFG GLGGYWRALQ RGREGRTMTS RASELSPGRS VTAGIIIVGD
     EILKGHTQDT NTFFLCRTLR SLGVQVCRVS VVPDEVATIA AEVTSFSNRF THVLTAGGIG
     PTHDDVTFEA VAQAFGDELK PHPKLEAATK ALGGEGWEKL SLVPSSARLH YGTDPCTGQP
     FRFPLVSVRN VYLFPGIPEL LRRVLEGMKG LFQNPAVQFH SKELYVAADE ASIAPILAEA
     QAHFGRRLGL GSYPDWGSNY YQVKLTLDSE EEGPLEECLA YLTARLPQGS LVPYMPNAVE
     QASEAVYKLA ESGSSLGKKV AGALQTIETS LAQYSLTQLC VGFNGGKDCT ALLHLFHAAV
     QRKLPDVPNP LQILYIRSIS PFPELEQFLQ DTIKRYNLQM LEAEGSMKQA LGELQARHPQ
     LEAVLMGTRR TDPYSCSLCP FSPTDPGWPA FMRINPLLDW TYRDIWDFLR QLFVPYCILY
     DRGYTSLGSR ENTVRNPALK CLSPGGHPTY RPAYLLENEE EERNSRT
//
